| scholarly article | Q13442814 |
| P50 | author | Gian Maria Rossolini | Q28323988 |
| Elisabetta Nucleo | Q56487481 | ||
| Roberta Migliavacca | Q56487483 | ||
| Laura Pagani | Q56487485 | ||
| Melissa Spalla | Q57414393 | ||
| P2093 | author name string | Rossana Daturi | |
| Elisabetta Mantengoli | |||
| Simona Pollini | |||
| Egidio Romero | |||
| P2860 | cites work | Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains | Q74162144 |
| beta-Lactamases in laboratory and clinical resistance | Q24669605 | ||
| Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing | Q29614699 | ||
| Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases | Q33747422 | ||
| Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase | Q33972291 | ||
| Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece | Q33974461 | ||
| Prescribing guidelines for severe Pseudomonas infections | Q34508864 | ||
| Emerging carbapenemases in Gram-negative aerobes | Q34707048 | ||
| Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact | Q35183983 | ||
| Properties of IncP-2 plasmids of Pseudomonas spp. | Q35749305 | ||
| Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa | Q35814019 | ||
| Rapid procedure for detection and isolation of large and small plasmids | Q36320743 | ||
| Isolation of large bacterial plasmids and characterization of the P2 incompatibility group plasmids pMG1 and pMG5 | Q36469957 | ||
| Emerging extended-spectrum beta-lactamases in Proteus mirabilis | Q39697527 | ||
| Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase | Q39781579 | ||
| Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study | Q39785102 | ||
| Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. | Q43587157 | ||
| An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit | Q43685434 | ||
| Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? | Q43874264 | ||
| PER-1 extended-spectrum beta-lactamase production in an Alcaligenes faecalis clinical isolate resistant to expanded-spectrum cephalosporins and monobactams from a hospital in Northern Italy | Q50120564 | ||
| Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4 | Q53932439 | ||
| Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa | Q72259493 | ||
| Outbreak of extended-spectrum beta-lactamase producing Serratia marcescens in an intensive care unit | Q72586702 | ||
| Hybridization of nucleic acids directly in agarose gels | Q72711217 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Italy | Q38 |
| Pseudomonas aeruginosa | Q31856 | ||
| multiple drug resistance | Q643839 | ||
| P304 | page(s) | 2523-2529 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy | |
| P478 | volume | 42 |
| Q54089542 | Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study. |
| Q42819064 | Antimicrobial Resistance Patterns and Prevalence of blaPER-1 and blaVEB-1 Genes Among ESBL-producing Pseudomonas aeruginosa Isolates in West of Iran |
| Q35911929 | Antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from a Malaysian Hospital |
| Q91634632 | Association of biofilm formation with multi drug resistance in clinical isolates of Pseudomonas aeruginosa |
| Q42947069 | BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa |
| Q42112187 | Biochemical characterization of PER-2 and genetic environment of blaPER-2 |
| Q34071886 | Burn Patients Infected With Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa: Multidrug-Resistant Strains |
| Q45945782 | Characterization of extended-spectrum beta-lactamases in Enterobacteriaceae causing nosocomial infections in a Zagreb University Hospital. |
| Q38423644 | Characterization of the extended-spectrum β-lactamases and determination of the virulence factors of uropathogenic Escherichia coli strains isolated from children. |
| Q38544980 | Detection of expanded-spectrum β-lactamases in Gram-negative bacteria in the 21st century |
| Q43151613 | Detection of extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa |
| Q57225241 | Dissemination of ceftazidime-resistant Acinetobacter baumannii clonal complex 92 in Korea |
| Q35917817 | Emergence of integron borne PER-1 mediated extended spectrum cephalosporin resistance among nosocomial isolates of Gram-negative bacilli. |
| Q39739670 | Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia. |
| Q24534999 | Extended-spectrum beta-lactamases: a clinical update |
| Q33770194 | Genetic environment and expression of the extended-spectrum beta-lactamase blaPER-1 gene in gram-negative bacteria |
| Q39245554 | Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary |
| Q34737402 | Interspecies dissemination of the bla gene encoding PER-1 extended-spectrum β-lactamase |
| Q37809057 | Minor extended-spectrum β-lactamases. |
| Q46735380 | Molecular epidemiology of PER-1 extended spectrum beta-lactamase among gram-negative bacteria isolated at a tertiary care hospital |
| Q33722024 | Novel TEM-type extended-spectrum beta-lactamase, TEM-134, in a Citrobacter koseri clinical isolate |
| Q43446878 | Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem |
| Q36098603 | Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex |
| Q64118346 | Phenotypic and Genotypic Characterization of spp. Panel Strains: A Cornerstone to Facilitate Antimicrobial Development |
| Q99732108 | Prevalence of antibiotic-resistant, toxic metal-tolerant and biofilm-forming bacteria in hospital surroundings |
| Q42546625 | Prevalence of multidrug resistant and extended spectrum beta-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital |
| Q33236778 | Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase |
| Q33938238 | Tn5393d, a complex Tn5393 derivative carrying the PER-1 extended-spectrum beta-lactamase gene and other resistance determinants. |
Search more.